Stage IVA Prostate Cancer AJCC v8 Recruiting Phase 2 Trials for Goserelin (DB00014)

IndicationStatusPhase
DBCOND0109674 (Stage IVA Prostate Cancer AJCC v8)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04734730Talazoparib With Androgen Deprivation Therapy and Abiraterone for the Treatment of Castration Sensitive Prostate CancerTreatment